[54] Cost, Access, and Adherence Access to anti-obesity medications is limited by cost, insurance coverage, prior authorization requirements, medication shortages, and long-term adherence
Saxenda (liraglutide) for weight management Saxenda, the older daily-injection GLP-1 agonist from Novo Nordisk, was also dropped from weight management coverage
The Medical Minute: Hernia the common, treatable condition no one is talking about While an impending storm will trigger cautionary news reports about the risk of a heart attack while shoveling snow, youre less likely to hear how twisting and turning while moving heavy amounts of the tiny ice crystals may increase your risk of developing a hernia
doi: 10.1038/jcbfm.2011.51 136 PadmasekarMLingwalNSamikannuBChenCSauerHLinnT
Frequently Asked Questions Can I expect to see weight loss in the first week of GLP-1 treatment
Flavor: Island Pineapple